[Ip-health] Cancer Group Recommendations To Ensure Medicines Access In South Africa Draft IP Policy

Kim Treanor kim.treanor at keionline.org
Fri Oct 13 11:35:55 PDT 2017


Cancer Group Recommendations To Ensure Medicines Access In South Africa
Draft IP Policy
IP Watch, 13 October 2017

A US cancer group has provided a series of recommendations to the South
African government on ways to improve the country’s draft national
intellectual property policy, including greater transparency, voluntary
licensing, and the use of compulsory licences.

The Union of Affordable Cancer Treatment (UACT) wrote a letter to the South
African Minister of Trade and Industry raising concerns about the South
African draft national policy on intellectual property.

The detailed 10 October letter was sent by the Union for Affordable Cancer
Treatment to South Africa Minister of Trade and Industry Rob Davies.

The letter calls for a transparency requirement on all royalties on patents
granted in South Africa. It also suggests that to ensure adequate access
where there is a public interest, the South Africa Ministry of Health
should be allowed to require the manufacturers of drugs or vaccines to
disclose the units sold in the country.

On the topic of de-linkage of research and development costs and the market
price of medicines, South Africa should encourage the World Health
Organization, UNITAID or another body to undertake a study of the
feasibility of delinking prices for cancer drugs, a proposal that was
debated during the 2017 World Health Assembly in the resolution on cancer,
the letter says.


Kim Treanor
Knowledge Ecology International
kim.treanor at keionline.org
tel.: +1.202.332.2670

More information about the Ip-health mailing list